Cyclerion Therapeutics Ownership 2024 | Who Owns Cyclerion Therapeutics Now?
Institutional Ownership
0.02%
Insider Ownership
21.90%
Retail Ownership
78.07%
Institutional Holders
1.00
Cyclerion Therapeutics Institutional Shareholders
Institutional Shareholders by % of Total Shares
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
ARTAL GROUP S.A. | - | - | - | -552 | -100.00% | - | Dec 31, 2023 |
Cyclerion Therapeutics's largest institutional shareholder is ARTAL GROUP S.A., holding 0.00% of the company's total share outstanding, currently valued at -. The top 10 institutional shareholders own together 0.00% of the company.
Institutional Shareholders by % of Total Assets
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
ARTAL GROUP S.A. | - | - | - | -552 | -100.00% | - | Dec 31, 2023 |
The largest Cyclerion Therapeutics shareholder by % of total assets is ARTAL GROUP S.A.. The company owns 0.00 shares of Cyclerion Therapeutics (CYCN), representing 0.00% of its total assets.
Institutional Buyers
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
ARTAL GROUP S.A. | - | - | - | -552 | -100.00% | - | Dec 31, 2023 |
As of Dec 31 2023, Cyclerion Therapeutics's largest institutional buyer is ARTAL GROUP S.A.. The company purchased -0.55K stocks of CYCN, valued at -.
Institutional Sellers
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
ARTAL GROUP S.A. | - | - | - | -552 | -100.00% | - | Dec 31, 2023 |
As of Dec 31 2023, Cyclerion Therapeutics's biggest institutional seller is ARTAL GROUP S.A.. The company sold -0.55K shares of CYCN, valued at -.
Institutional New positions
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|
Institutional Sold Out
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
ARTAL GROUP S.A. | - | - | - | -552 | -100.00% | - | Dec 31, 2023 |
Cyclerion Therapeutics's largest sold out institutional shareholder by shares sold is ARTAL GROUP S.A., sold -0.55K shares, valued at -, as of undefined.
Cyclerion Therapeutics Mutual Fund Holders
Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
---|---|---|---|---|---|
T. Rowe Price Health Sciences Fund, Inc. | 0.17% | 579,827 | - | - | Mar 31, 2024 |
UBS RELATIONSHIP FUNDS | 0.10% | 23,269 | - | - | Jun 30, 2020 |
FIDELITY COMMONWEALTH TRUST | 0.07% | 227,375 | - | - | Feb 29, 2024 |
Brown Capital Management Mutual Funds | 0.06% | 174,196 | - | - | Dec 31, 2023 |
BRIDGEWAY FUNDS INC | 0.05% | 107,000 | - | - | Mar 28, 2024 |
VANGUARD VALLEY FORGE FUNDS | 0.04% | 23,450 | - | - | Mar 31, 2024 |
FIDELITY MT VERNON STREET TRUST | 0.03% | 795,260 | - | - | Feb 29, 2024 |
VANGUARD SPECIALIZED FUNDS | 0.02% | 989,481 | - | - | Jan 31, 2024 |
T. Rowe Price Equity Series, Inc. | 0.02% | 26,300 | - | - | Mar 31, 2024 |
Vericimetry Funds | 0.02% | 1,400 | - | - | Mar 31, 2024 |
FIDELITY SELECT PORTFOLIOS | 0.01% | 837,285 | - | - | Feb 29, 2024 |
QUANTITATIVE MASTER SERIES LLC | 0.01% | 38,797 | - | - | Mar 31, 2024 |
DEUTSCHE DWS INVESTMENTS VIT FUNDS | 0.01% | 3,714 | - | - | Mar 31, 2024 |
VANGUARD EXPLORER FUND | 0.01% | 73,838 | - | - | Jan 31, 2024 |
UBS FUNDS | 0.01% | 28,574 | - | - | Mar 31, 2024 |
FIDELITY COMMONWEALTH TRUST | 0.00% | 13,840 | 853 | 6.57% | Feb 29, 2024 |
VANGUARD INDEX FUNDS | 0.00% | 1,608,075 | - | - | Mar 31, 2024 |
FIRST TRUST EXCHANGE-TRADED FUND | 0.00% | 31,721 | - | - | Mar 31, 2024 |
TIAA SEPARATE ACCOUNT VA 1 | 0.00% | 528 | - | - | Mar 31, 2024 |
BRIDGEWAY FUNDS INC | 0.00% | 5,350 | - | - | Mar 28, 2024 |
JNL VARIABLE FUND LLC | 0.00% | 11,107 | - | - | Mar 31, 2020 |
FIDELITY CONCORD STREET TRUST | 0.00% | 341,933 | - | - | Feb 29, 2024 |
FIDELITY MT VERNON STREET TRUST | 0.00% | 32,351 | -2,226 | -6.44% | Feb 29, 2024 |
T. Rowe Price New Horizons Fund, Inc. | 0.00% | 4,330 | - | - | Mar 31, 2024 |
VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00% | 26,426 | - | - | Mar 31, 2024 |
Calvert Variable Products, Inc. | 0.00% | 2,036 | - | - | Mar 31, 2024 |
VANGUARD VARIABLE INSURANCE FUNDS | 0.00% | 37,118 | - | - | Mar 31, 2024 |
FIDELITY SELECT PORTFOLIOS | 0.00% | 41,864 | - | - | Feb 29, 2024 |
Nushares ETF Trust | 0.00% | 3,649 | - | - | Jan 31, 2024 |
Fidelity Commonwealth Trust II | 0.00% | 2,954 | - | - | Aug 31, 2023 |
Voya VARIABLE PORTFOLIOS INC | 0.00% | 12,043 | - | - | Mar 31, 2024 |
SCHWAB CAPITAL TRUST | 0.00% | 15,496 | - | - | Feb 29, 2024 |
GPS Funds I | 0.00% | 1,918 | - | - | Mar 31, 2024 |
INVESCO EXCHANGE-TRADED FUND TRUST | 0.00% | 29,104 | - | - | Jan 31, 2024 |
SunAmerica Specialty Series | 0.00% | 183 | - | - | Apr 30, 2021 |
PFM Multi-Manager Series Trust | 0.00% | 260 | - | - | Dec 31, 2023 |
FIDELITY COVINGTON TRUST | 0.00% | 5,552 | - | - | Jan 31, 2024 |
HARTFORD SERIES FUND INC | 0.00% | 12,257 | - | - | Mar 31, 2024 |
SCHWAB STRATEGIC TRUST | 0.00% | 151,796 | - | - | Feb 29, 2024 |
VANGUARD WORLD FUND | 0.00% | 54,046 | - | - | Feb 29, 2024 |
Columbia Funds Variable Series Trust II | 0.00% | 4,848 | - | - | Mar 31, 2024 |
Meeder Funds | 0.00% | 733 | - | - | Mar 31, 2024 |
HC CAPITAL TRUST | 0.00% | 4,348 | - | - | Mar 31, 2024 |
JOHN HANCOCK INVESTMENT TRUST | 0.00% | 10,043 | - | - | Mar 31, 2024 |
VARIABLE INSURANCE PRODUCTS FUND II | 0.00% | 1,070 | - | - | Mar 31, 2024 |
FIDELITY CONCORD STREET TRUST | 0.00% | 16,885 | -47 | -0.28% | Feb 29, 2024 |
NORTHERN FUNDS | 0.00% | 11,633 | - | - | Mar 28, 2024 |
TIAA-CREF LIFE FUNDS | 0.00% | 208 | - | - | Mar 31, 2024 |
PGIM ETF TRUST | 0.00% | 4,406 | - | - | Feb 29, 2024 |
ALLSPRING MASTER TRUST | 0.00% | 4,290 | - | - | Feb 29, 2024 |
STATE STREET INSTITUTIONAL INVESTMENT TRUST | 0.00% | 3,740 | - | - | Mar 31, 2024 |
VANGUARD INDEX FUNDS | 0.00% | 23,490 | -23,490 | -50.00% | Mar 31, 2024 |
FIDELITY SALEM STREET TRUST | 0.00% | 169,863 | - | - | Mar 31, 2024 |
ProFunds | 0.00% | 481 | - | - | Mar 31, 2024 |
COLLEGE RETIREMENT EQUITIES FUND | 0.00% | 43,203 | - | - | Mar 31, 2024 |
PACE SELECT ADVISORS TRUST | 0.00% | 12,599 | - | - | Jan 31, 2024 |
VALIC Co I | 0.00% | 10,513 | - | - | Feb 29, 2024 |
PENN SERIES FUNDS INC | 0.00% | 976 | - | - | Mar 28, 2024 |
VANGUARD SCOTTSDALE FUNDS | 0.00% | 66,264 | - | - | Feb 29, 2024 |
RUSSELL INVESTMENT CO | 0.00% | 9,911 | - | - | Jan 31, 2024 |
NATIONWIDE VARIABLE INSURANCE TRUST | 0.00% | 3,820 | - | - | Mar 31, 2024 |
NATIONWIDE MUTUAL FUNDS | 0.00% | 3,225 | - | - | Jan 31, 2024 |
RUSSELL INVESTMENT FUNDS | 0.00% | 2,399 | - | - | Mar 31, 2024 |
USAA MUTUAL FUNDS TRUST | 0.00% | 3,849 | - | - | Jan 31, 2024 |
SPDR INDEX SHARES FUNDS | 0.00% | 3,254 | - | - | Mar 31, 2024 |
Brighthouse Funds Trust II | 0.00% | 12,605 | - | - | Mar 31, 2024 |
LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 0.00% | 28,487 | - | - | Mar 31, 2024 |
MORGAN STANLEY PATHWAY FUNDS | 0.00% | 993 | - | - | Feb 29, 2024 |
Legg Mason Global Asset Management Trust | 0.00% | 75,786 | - | - | Jan 31, 2024 |
HARTFORD MUTUAL FUNDS INC/CT | 0.00% | 77,471 | - | - | Jan 31, 2024 |
T. Rowe Price Index Trust, Inc. | 0.00% | 198 | - | - | Feb 29, 2024 |
DFA INVESTMENT DIMENSIONS GROUP INC | 0.00% | 8,757 | - | - | Jan 31, 2024 |
SUNAMERICA SERIES TRUST | 0.00% | 3,133 | - | - | Mar 31, 2024 |
EQ ADVISORS TRUST | 0.00% | 6,103 | - | - | Mar 31, 2024 |
PACIFIC SELECT FUND | 0.00% | 16,928 | - | - | Mar 31, 2024 |
ADVANCED SERIES TRUST | 0.00% | 14,100 | - | - | Mar 28, 2024 |
Blackstone Alternative Investment Funds | 0.00% | 200 | - | - | Mar 31, 2023 |
iShares U.S. ETF Trust | 0.00% | 330 | - | - | Jan 31, 2024 |
MASSMUTUAL SELECT FUNDS | 0.00% | 2,767 | - | - | Dec 31, 2023 |
Bridge Builder Trust | 0.00% | 8,810 | - | - | Mar 31, 2024 |
J.P. Morgan Exchange-Traded Fund Trust | 0.00% | 740 | - | - | Jan 31, 2024 |
JOHN HANCOCK VARIABLE INSURANCE TRUST | 0.00% | 2,735 | - | - | Mar 31, 2024 |
John Hancock Funds II | 0.00% | 15,848 | - | - | Feb 29, 2024 |
iSHARES TRUST | 0.00% | 16,580 | - | - | Mar 31, 2024 |
USAA MUTUAL FUNDS TRUST | 0.00% | 209 | - | - | Jan 31, 2024 |
BlackRock Variable Series Funds, Inc. | 0.00% | 3,184 | - | - | Mar 31, 2024 |
Legg Mason Global Asset Management Trust | 0.00% | 3,789 | - | - | Jan 31, 2024 |
SUNAMERICA SERIES TRUST | 0.00% | 156 | - | - | Mar 31, 2024 |
PRINCIPAL FUNDS, INC. | 0.00% | 2,315 | - | - | Feb 29, 2024 |
WILSHIRE MUTUAL FUNDS INC | 0.00% | 100 | - | - | Dec 31, 2023 |
BLACKROCK FUNDS | 0.00% | 1,865 | - | - | Mar 28, 2024 |
Advisors' Inner Circle Fund III | 0.00% | 17 | - | - | Jan 31, 2024 |
SEI INSTITUTIONAL INVESTMENTS TRUST | 0.00% | 2,425 | - | - | Feb 29, 2024 |
Cyclerion Therapeutics's largest mutual fund holder by % of total assets is "T. Rowe Price Health Sciences Fund, Inc.", owning 579.83K shares, compromising 0.17% of its total assets.
Cyclerion Therapeutics Institutional Ownership Trends
Institutional Holdings Trend
Date | Holdings | Change % |
---|---|---|
30 Sep, 23 | 1 | - |
30 Jun, 23 | 1 | -97.06% |
31 Mar, 23 | 34 | -17.07% |
31 Dec, 22 | 41 | 28.13% |
30 Sep, 22 | 32 | -11.11% |
30 Jun, 22 | 36 | -20.00% |
31 Mar, 22 | 45 | -15.09% |
31 Dec, 21 | 53 | -11.67% |
30 Sep, 21 | 60 | -9.09% |
30 Jun, 21 | 66 | -5.71% |
31 Mar, 21 | 70 | 1.45% |
31 Dec, 20 | 69 | - |
30 Sep, 20 | 69 | -1.43% |
30 Jun, 20 | 70 | -1.41% |
31 Mar, 20 | 71 | - |
31 Dec, 19 | 71 | -17.44% |
30 Sep, 19 | 86 | -9.47% |
30 Jun, 19 | 95 | 2275.00% |
31 Mar, 19 | 4 | - |
As of 30 Sep 23, 1 institutions are holding Cyclerion Therapeutics's shares, representing an increase of 0.00% compared to the previous quarter.
Shares Outstanding Trend
Date | Shares Outstanding | Change % |
---|---|---|
30 Sep, 23 | 552 | - |
30 Jun, 23 | 552 | -100.00% |
31 Mar, 23 | 20,630,091 | -0.95% |
31 Dec, 22 | 20,827,663 | -1.93% |
30 Sep, 22 | 21,238,228 | 1.59% |
30 Jun, 22 | 20,905,151 | -8.94% |
31 Mar, 22 | 22,957,892 | -2.60% |
31 Dec, 21 | 23,569,938 | -4.15% |
30 Sep, 21 | 24,589,243 | 0.32% |
30 Jun, 21 | 24,510,831 | 9.43% |
31 Mar, 21 | 22,398,027 | 2.51% |
31 Dec, 20 | 21,850,647 | -5.70% |
30 Sep, 20 | 23,172,311 | 30.89% |
30 Jun, 20 | 17,703,947 | -4.46% |
31 Mar, 20 | 18,531,143 | 20.46% |
31 Dec, 19 | 15,383,273 | -21.30% |
30 Sep, 19 | 19,547,939 | 0.81% |
30 Jun, 19 | 19,391,723 | 2167.89% |
31 Mar, 19 | 855,056 | - |
Cyclerion Therapeutics (CYCN) has 552.00 shares outstanding as of 30 Sep 23, up 0.00% compared to the previous quarter.
Institutional Ownership Trend
Date | Ownership % | Change % |
---|---|---|
30 Sep, 23 | 0.02% | 3754.33% |
30 Jun, 23 | 0.03% | 0.00% |
31 Mar, 23 | 47.40% | 2.07% |
31 Dec, 22 | 47.86% | 2.01% |
30 Sep, 22 | 48.80% | 2.11% |
30 Jun, 22 | 48.03% | 1.73% |
31 Mar, 22 | 52.75% | 0.88% |
31 Dec, 21 | 77.53% | 1.19% |
30 Sep, 21 | 80.88% | 1.24% |
30 Jun, 21 | 80.62% | 1.49% |
31 Mar, 21 | 73.67% | 1.43% |
31 Dec, 20 | 71.87% | 1.24% |
30 Sep, 20 | 76.22% | 1.82% |
30 Jun, 20 | 64.66% | 1.41% |
31 Mar, 20 | 67.68% | 2.14% |
31 Dec, 19 | 56.18% | 1.10% |
30 Sep, 19 | 71.39% | 1.42% |
30 Jun, 19 | 70.82% | 1.82% |
31 Mar, 19 | 62.46% | - |
As of 30 Sep 23, Cyclerion Therapeutics is held by 0.02% institutional shareholders, representing a 3754.33% growth compared to 30 Jun 23.
Institutional Increased Positions Trend
Date | Increased Positions | Change % |
---|---|---|
30 Sep, 23 | - | - |
30 Jun, 23 | - | -100.00% |
31 Mar, 23 | 7 | -63.16% |
31 Dec, 22 | 19 | 216.67% |
30 Sep, 22 | 6 | -50.00% |
30 Jun, 22 | 12 | -14.29% |
31 Mar, 22 | 14 | -36.36% |
31 Dec, 21 | 22 | -15.38% |
30 Sep, 21 | 26 | -10.34% |
30 Jun, 21 | 29 | -14.71% |
31 Mar, 21 | 34 | -5.56% |
31 Dec, 20 | 36 | 24.14% |
30 Sep, 20 | 29 | - |
30 Jun, 20 | 29 | -14.71% |
31 Mar, 20 | 34 | -10.53% |
31 Dec, 19 | 38 | -9.52% |
30 Sep, 19 | 42 | -54.35% |
30 Jun, 19 | 92 | 2200.00% |
31 Mar, 19 | 4 | - |
- institutional shareholders have increased their position in CYCN stock as of 30 Sep 23 compared to - in the previous quarter (a 0.00% increase).
Institutional Reduced Positions Trend
Date | Reduced Positions | Change % |
---|---|---|
30 Sep, 23 | - | -100.00% |
30 Jun, 23 | 1 | -92.31% |
31 Mar, 23 | 13 | 62.50% |
31 Dec, 22 | 8 | -27.27% |
30 Sep, 22 | 11 | - |
30 Jun, 22 | 11 | -38.89% |
31 Mar, 22 | 18 | 50.00% |
31 Dec, 21 | 12 | -36.84% |
30 Sep, 21 | 19 | -5.00% |
30 Jun, 21 | 20 | 25.00% |
31 Mar, 21 | 16 | -11.11% |
31 Dec, 20 | 18 | -25.00% |
30 Sep, 20 | 24 | -4.00% |
30 Jun, 20 | 25 | 13.64% |
31 Mar, 20 | 22 | 29.41% |
31 Dec, 19 | 17 | - |
30 Sep, 19 | 17 | 750.00% |
30 Jun, 19 | 2 | - |
31 Mar, 19 | - | - |
- institutional shareholders have reduced their position in CYCN stock as of 30 Sep 23 compared to 1 in the previous quarter (a -100.00% decrease).
All Institutional Ownership Trend Data
Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
---|---|---|---|---|---|---|---|---|---|---|
30 Sep, 23 | 1 | - | 552 | - | 0.02% | 3754.33% | - | - | - | -100.00% |
30 Jun, 23 | 1 | -97.06% | 552 | -100.00% | 0.03% | 0.00% | - | -100.00% | 1 | -92.31% |
31 Mar, 23 | 34 | -17.07% | 20,630,091 | -0.95% | 47.40% | 2.07% | 7 | -63.16% | 13 | 62.50% |
31 Dec, 22 | 41 | 28.13% | 20,827,663 | -1.93% | 47.86% | 2.01% | 19 | 216.67% | 8 | -27.27% |
30 Sep, 22 | 32 | -11.11% | 21,238,228 | 1.59% | 48.80% | 2.11% | 6 | -50.00% | 11 | - |
30 Jun, 22 | 36 | -20.00% | 20,905,151 | -8.94% | 48.03% | 1.73% | 12 | -14.29% | 11 | -38.89% |
31 Mar, 22 | 45 | -15.09% | 22,957,892 | -2.60% | 52.75% | 0.88% | 14 | -36.36% | 18 | 50.00% |
31 Dec, 21 | 53 | -11.67% | 23,569,938 | -4.15% | 77.53% | 1.19% | 22 | -15.38% | 12 | -36.84% |
30 Sep, 21 | 60 | -9.09% | 24,589,243 | 0.32% | 80.88% | 1.24% | 26 | -10.34% | 19 | -5.00% |
30 Jun, 21 | 66 | -5.71% | 24,510,831 | 9.43% | 80.62% | 1.49% | 29 | -14.71% | 20 | 25.00% |
31 Mar, 21 | 70 | 1.45% | 22,398,027 | 2.51% | 73.67% | 1.43% | 34 | -5.56% | 16 | -11.11% |
31 Dec, 20 | 69 | - | 21,850,647 | -5.70% | 71.87% | 1.24% | 36 | 24.14% | 18 | -25.00% |
30 Sep, 20 | 69 | -1.43% | 23,172,311 | 30.89% | 76.22% | 1.82% | 29 | - | 24 | -4.00% |
30 Jun, 20 | 70 | -1.41% | 17,703,947 | -4.46% | 64.66% | 1.41% | 29 | -14.71% | 25 | 13.64% |
31 Mar, 20 | 71 | - | 18,531,143 | 20.46% | 67.68% | 2.14% | 34 | -10.53% | 22 | 29.41% |
31 Dec, 19 | 71 | -17.44% | 15,383,273 | -21.30% | 56.18% | 1.10% | 38 | -9.52% | 17 | - |
30 Sep, 19 | 86 | -9.47% | 19,547,939 | 0.81% | 71.39% | 1.42% | 42 | -54.35% | 17 | 750.00% |
30 Jun, 19 | 95 | 2275.00% | 19,391,723 | 2167.89% | 70.82% | 1.82% | 92 | 2200.00% | 2 | - |
31 Mar, 19 | 4 | - | 855,056 | - | 62.46% | - | 4 | - | - | - |
Cyclerion Therapeutics Insider Shareholders Trades
Open Market Insider Trades
Open Market Insider Buys
Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
---|
Insider Sells
All Insider Owners Trades
The last insider sell of Cyclerion Therapeutics's stock was made by CHICKO RHONDA M. on Mar 11 2024, selling - shares at - per share (valued at -).
Cyclerion Therapeutics Insider Ownership Trends
All Insider Trades Trend
Date | Buy | Sell | Buy/Sell Ratio |
---|---|---|---|
Q3 2024 | 1 | - | - |
Q1 2024 | 2 | 1 | 200.00% |
Q4 2023 | 6 | 4 | 150.00% |
Q3 2023 | - | 1 | - |
Q2 2023 | 2 | - | - |
Q3 2022 | 2 | - | - |
Q2 2022 | 12 | - | - |
Q1 2022 | 5 | - | - |
Q4 2021 | 3 | - | - |
Q2 2021 | 17 | 1 | 1700.00% |
Q1 2021 | - | 35 | - |
Q4 2020 | 3 | 10 | 30.00% |
Q3 2020 | - | - | - |
Q2 2020 | 8 | - | - |
Q1 2020 | 1 | 1 | 100.00% |
Q4 2019 | 5 | 3 | 166.67% |
Q3 2019 | 1 | 1 | 100.00% |
Q2 2019 | 82 | 1 | 8200.00% |
Q1 2019 | 1 | 1 | 100.00% |
1 total buy trades, and 0 total sell trades (buy/sell ratio of 0%) were made by Cyclerion Therapeutics's insiders, as of Q3 2024.
Open Market Insider Trades Trend
Date | Buy | Sell | Buy/Sell Ratio |
---|---|---|---|
Q3 2024 | - | - | - |
Q1 2024 | - | - | - |
Q4 2023 | - | - | - |
Q3 2023 | - | 1 | - |
Q2 2023 | - | - | - |
Q3 2022 | - | - | - |
Q2 2022 | - | - | - |
Q1 2022 | - | - | - |
Q4 2021 | - | - | - |
Q2 2021 | 9 | - | - |
Q1 2021 | - | 2 | - |
Q4 2020 | 2 | 2 | 100.00% |
Q3 2020 | - | - | - |
Q2 2020 | - | - | - |
Q1 2020 | - | 1 | - |
Q4 2019 | 1 | 3 | 33.33% |
Q3 2019 | - | - | - |
Q2 2019 | 5 | - | - |
Q1 2019 | - | - | - |
As of Q3 2024, Insider owners conducted 0 open market buy trades and 0 open market sell trades of Cyclerion Therapeutics's stocks.
Cyclerion Therapeutics Peer Ownership
Ticker | Company |
---|---|
SNTI | Senti Biosciences, Inc. |
ZVSA | ZyVersa Therapeutics, Inc. |
MGTA | Dianthus Therapeutics, Inc. |
XFOR | X4 Pharmaceuticals, Inc. |
CFRX | ContraFect Corporation |
AXLA | Axcella Health Inc. |
MNPR | Monopar Therapeutics Inc. |
ACHL | Achilles Therapeutics plc |
LRMR | Larimar Therapeutics, Inc. |
ERAS | Erasca, Inc. |
FENC | Fennec Pharmaceuticals Inc. |
SGTX | Sigilon Therapeutics, Inc. |
KRON | Kronos Bio, Inc. |
SONN | Sonnet BioTherapeutics Holdings, Inc. |
LIPO | Lipella Pharmaceuticals Inc. |
ADXN | Addex Therapeutics Ltd |
KZR | Kezar Life Sciences, Inc. |
FBRX | Forte Biosciences, Inc. |
CDIO | Cardio Diagnostics Holdings, Inc. |
CYCN Ownership FAQ
Who Owns Cyclerion Therapeutics?
Cyclerion Therapeutics is owned by institutional shareholders (0.02%), insiders (21.90%), and public (78.07%). The largest institutional shareholder of Cyclerion Therapeutics is ARTAL GROUP S.A. (0% of total shares) and the top mutual fund owner is T. Rowe Price Health Sciences Fund, Inc. (0.17% of total shares).
Who are the major institutional shareholders of Cyclerion Therapeutics?
Cyclerion Therapeutics's major institutional shareholders are ARTAL GROUP S.A.. The top five shareholders own together 0% of the company's share outstanding.
How many Cyclerion Therapeutics shareholders are there?
As of Sep 2023, there are 1 institutional shareholders of Cyclerion Therapeutics.
What percentage of Cyclerion Therapeutics is owned by ARTAL GROUP S.A?
ARTAL GROUP S.A owns 0 shares of Cyclerion Therapeutics, representing 0% of the company's total shares outstanding, valued at $0 (as of Dec 2023).